Novartis has completed the planned spin-off of its generics and biosimilars business, Sandoz, which will begin trading on the SIX Swiss Exchange on Wednesday.
Source:https://www.cnbc.com/2023/10/04/novartis-unit-sandoz-completes-spinoff.html
Source:https://www.cnbc.com/2023/10/04/novartis-unit-sandoz-completes-spinoff.html
© 2010-2022 Billy Tang
Supported By Growth SpeedUp Company
© 2010-2022 Billy Tang
Supported By Growth SpeedUp Company
Subscribe now to keep reading and get access to the full archive.